Tradestie Institutional Equity Comparison Engine
DXR vs AMS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXR Overall Edge
DXR Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Daxor Corporation Common Stock (DXR) driven by superior Growth & Margin, Momentum & Technical while AMS counters with relative strength in Valuation. Fundamentally, DXR trades at 64.5x Forward P/E with -5894.3% operating margin (+25.5% YoY revenue) versus AMS at 44.6x Forward P/E and -7.4% operating margin (+19.2% YoY). In options structure, DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AMS
DXR 64.5x vs AMS 44.6x Fwd P/E
Growth & Margin Winner
DXR
Op Margin -5894.3% vs -7.4% ยท YoY +25.5% vs +19.2%
Momentum & Technical Winner
DXR
1Y -38.3% vs -52.2% ยท 52W Pos 2% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DXR
NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap
$49.5M
1M Return
-16.87%
1Y Return
-38.29%
Forward P/E
64.5x
Unified AI Score
52.2 / 100
HOLD
Tech 52.0
Fund 59.0
Flow 50.0
Mom 64.0
AMS
NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap
$7.2M
1M Return
-16.41%
1Y Return
-52.23%
Forward P/E
44.6x
Unified AI Score
33.8 / 100
SELL
Tech 24.0
Fund 38.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DXR -38.29%
AMS -52.23%
Spread: +18.96 pp (DXR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
DXR TTM Op. Margin: -5894.3%
AMS TTM Op. Margin: -7.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DXR vs AMS. Trailing 12-month operating profitability (DXR -5894.3% vs AMS -7.4%) and valuation multiples (DXR 64.5x vs AMS 44.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXR | AMS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $49.5M | $7.2M | Larger Scale | DXR |
| Trailing P/E Ratio Valuation | 7.7x | 44.6x | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | 64.5x | 44.6x | Lower Multiple | AMS |
| Revenue Growth (YoY) Growth | +25.5% | +19.2% | Higher Growth | DXR |
| Operating Margin (TTM) Profitability | -5894.3% | -7.4% | Higher Margin | AMS |
| Net Profit Margin Profitability | 19861.4% | -5.8% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | 14.2% | -12.1% | Higher ROE | DXR |
| 52-Week Range Position Momentum | 2% ($8โ$15) | 6% ($1โ$2) | Stronger Trend | AMS |
| Beta / 30D Volatility Risk Regime | 0.28ฮฒ ยท 32% Vol | 0.18ฮฒ ยท 46% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 52.2 / 100 (HOLD) | 33.8 / 100 (SELL) | Higher Composite | DXR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DXR vs AMS Buy Guide
DXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AMS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DXR nor AMS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.